ICAM1 and neoplasm: Exosomes can be engineered to display ligands, such as ICAM-1 or LFA-1, which facilitate the recruitment of T cells by enhancing the adhesion and promoting immune cell trafficking to tumor sites (Nolte-'t Hoen et al., 2009; Segura et al., 2005).